Gurusamy Sivagnanam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gurusamy Sivagnanam has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- A. Aravinthan
Pharmacy, IGMC & RI(1), Puducherry, India
1 shared publication - Lourdu Jafrin Antony
Dept. of Pharmacology, IGMC & RI(1), Puducherry, India
1 shared publication - Rekha Priyadarshini
Department of Pharmacology, AIIMS Bibinagar , Hyderabad, Telangana
1 shared publication
Latest Publications
- 1 January 2021
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 17 (1) , 2044-2045
Rationing PPEs during a pandemic: The COVID-19 scenario
- 1 January 2021
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 17 (1) , 2044-2045
Rationing PPEs during a pandemic: The COVID-19 scenario
- Open Access
- 1 September 2016
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
- Vol. 7 (3) , 133-137
Deprescription: The prescription metabolism
Deprescribing is a structured approach to drug discontinuation. An alternative suggested term is "prescription metabolism." The major aim of deprescription is to purge the drug(s) considered unwanted in a given patient, especially in the elderly patients with multiple comorbidities or in those suffering from chronic disease. Like drug metabolism, prescription metabolism is a way of eliminating unwanted, troublesome, or cost-ineffective medications. The removal of such drugs has been found to decrease the incidence of adverse drug reactions and improves the rate of medication adherence, thereby reducing the economic burden on the patient as well as on the health care providers. Certain categories of drugs are to be tapered rather than abruptly stopped. Despite the availability of many tools to minimize drug therapy-related problems, there is little guidance for the process of deprescribing in general clinical practice. Various methods to reduce the risks of polypharmacy include patient education, physician education, and regulatory intervention. The suggested S and S approach (seek and screen, save and severe, sensitize and supervise) may be tried for deprescribing in general practice. More research on deprescribing is the need of the hour in almost all branches of clinical medicine which may pave the way for the betterment of health care.
- 1 September 2016
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
- Vol. 7 (3) , 133-137
Open AccessDeprescription: The prescription metabolism
Deprescribing is a structured approach to drug discontinuation. An alternative suggested term is "prescription metabolism." The major aim of deprescription is to purge the drug(s) considered unwanted in a given patient, especially in the elderly patients with multiple comorbidities or in those suffering from chronic disease. Like drug metabolism, prescription metabolism is a way of eliminating unwanted, troublesome, or cost-ineffective medications. The removal of such drugs has been found to decrease the incidence of adverse drug reactions and improves the rate of medication adherence, thereby reducing the economic burden on the patient as well as on the health care providers. Certain categories of drugs are to be tapered rather than abruptly stopped. Despite the availability of many tools to minimize drug therapy-related problems, there is little guidance for the process of deprescribing in general clinical practice. Various methods to reduce the risks of polypharmacy include patient education, physician education, and regulatory intervention. The suggested S and S approach (seek and screen, save and severe, sensitize and supervise) may be tried for deprescribing in general practice. More research on deprescribing is the need of the hour in almost all branches of clinical medicine which may pave the way for the betterment of health care.
- Open Access
- 1 June 2010
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
- Vol. 1 (1) , 4-8
Mesotherapy - The french connection
Mesotherapy involves the use of multiple intradermal or subcutaneous injections of a mixture of compounds in minute doses, by means of very fine needles, directly over/near the affected sites. Originally invented in France to manage painful medical conditions, it is presently the buzz word in the field of cosmetic dermatology, chiefly to get rid of disfiguring fat. Depending upon the condition treated, the drugs injected, the techniques followed and the number of sessions involved vary. The wider reception of mesotherapy by its stakeholders are probably due to factors like inexpensive equipments, relatively minimal training for providers, much reduced dosage need of the drugs with resultant minimal untoward effects, quicker realization of benefits, minimal invasiveness/pain involved and not the least it is an outpatient procedure. Despite so many plus points, it has to be noted that currently there is a dearth of rigorous scientific studies to prove its efficacy and safety. Further, the average cost per session alone ranges from 200 USD to 600 USD.
- 1 June 2010
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
- Vol. 1 (1) , 4-8
Open AccessMesotherapy - The french connection
Mesotherapy involves the use of multiple intradermal or subcutaneous injections of a mixture of compounds in minute doses, by means of very fine needles, directly over/near the affected sites. Originally invented in France to manage painful medical conditions, it is presently the buzz word in the field of cosmetic dermatology, chiefly to get rid of disfiguring fat. Depending upon the condition treated, the drugs injected, the techniques followed and the number of sessions involved vary. The wider reception of mesotherapy by its stakeholders are probably due to factors like inexpensive equipments, relatively minimal training for providers, much reduced dosage need of the drugs with resultant minimal untoward effects, quicker realization of benefits, minimal invasiveness/pain involved and not the least it is an outpatient procedure. Despite so many plus points, it has to be noted that currently there is a dearth of rigorous scientific studies to prove its efficacy and safety. Further, the average cost per session alone ranges from 200 USD to 600 USD.